LOW-DOSE GLUCOCORTICOIDS WITHDRAWN IN SYSTEMIC LUPUS ERYTHEMATOSUS: A DESIRABLE AND ATTAINABLE GOAL

ANNALS OF THE RHEUMATIC DISEASES(2022)

Cited 7|Views11
No score
Abstract
Low-dose GC is feasibly discontinued in real-life setting. SACQ and younger age are potential risk factors of SLE flare, while hydroxychloroquine usage and slow GC tapering to withdrawal can reduce relapse. The visualized model we developed may help to predict risk of flare among SLE patients who discontinued GC.
More
Translated text
Key words
Flare,Glucocorticoid,Predictors,Systemic lupus erythematosus,Withdrawal
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined